Contaminant or True Positive? How to Read a Blood Culture Result
A blood culture turns positive at 2 a.m.
The Gram stain shows coagulase-negative staphylococci. One bottle is positive. The patient is stable. The ward won't see the result until morning.
Now comes the question every microbiologist faces sooner or later: is this a bloodstream infection, or is it just a skin commensal?
The answer matters. Call contamination a pathogen and the patient may receive unnecessary vancomycin, extra investigations, and a longer hospital stay. Dismiss a true bacteraemia and you risk missing a life-threatening infection.
Most positive blood cultures are not difficult to interpret. Staphylococcus aureus, Escherichia coli, and Candida rarely need much debate. The challenge lies in the grey zone: coagulase-negative staphylococci, diphtheroids, Bacillus species, viridans streptococci, and other organisms that can be either contaminants or genuine pathogens depending on the circumstances.
Fortunately, the distinction is usually not guesswork. Before the identification or susceptibilities are even complete, four clues already tell most of the story:
- Who grew?
- How many bottles were positive?
- How quickly did the culture turn positive?
- What kind of patient did the organism come from?
Read those four signals together, and most blood cultures classify themselves long before the final report is issued.
First questionWho showed up?
Identity is the heaviest weight on the scale, because some organisms practically never lie and some lie almost every time.
There's a roster every microbiologist carries in their head. On one side, the organisms that mean business — recover them from blood and you believe them:
| Believe it — report and repeat | Doubt it — until the patient says otherwise |
|---|---|
| Staphylococcus aureus | Coagulase-negative staphylococci (CoNS) |
| Streptococcus pneumoniae | Corynebacterium spp. (diphtheroids) |
| Enterobacterales (E. coli, Klebsiella…) | Bacillus spp. (non-anthracis) |
| Pseudomonas aeruginosa | Cutibacterium / Propionibacterium |
| Candida and other yeasts | Micrococcus |
| Beta-haemolytic streptococci | Viridans streptococci (it depends) |
The left column means it. One bottle of S. aureus, of a streptococcus, of E. coli, of Candida — you report it, full identification and susceptibilities, and you ask for a repeat. No deliberation[1]. The right column is the cast of usual suspects: skin commensal flora and environmental drifters that hitch a ride during the draw[1][2].
But — and this is where the temptation is to sign out on autopilot — you never read the organism alone. You read it through the patient, because the lab requisition rarely tells you the whole story and you have to go looking for it. CoNS are the single most common contaminant we see and a genuine killer in exactly the patients who scare us: the ones with central lines, prosthetic valves, hardware, the neonates, the neutropenic[3][4][5]. Same bug. Opposite meaning. The patient decides which — which means before you call a CoNS "skin commensal," it's worth a glance at the ward it came from and a quick call to the unit if the ward is one of those.
Two names to tattoo on your memory:
- CoNS isn't always benign. Staphylococcus lugdunensis is a coagulase-negative staph by the bench definition, but it behaves like its vicious cousin S. aureus — it eats valves. Never wave it off as "just a skin commensal," and never let it get suppressed in a batch report as routine CoNS.
- Viridans strep keeps a double life. Often a contaminant; but in the right host — a febrile neutropenic with mucositis, or someone with a murmur and weeks of malaise — it's endocarditis announcing itself. Identity gives you the base rate. The patient tells you which way to bend it.
And resist the urge to over-read the species line. Pinning CoNS down to the exact species is satisfying on the bench, but on its own it hasn't reliably changed what clinicians do with the report[10]. It's a clue, not a confession.
Second questionHow many bottles, and did they agree?
This is the signal that decides more of our reports than any other — and the one most likely to be missing, because so many of our patients arrive with a single set drawn.
Picture the result two ways. The same organism blooming in both bottles of a set, or across two separate sets drawn from two separate sites — that's concordant growth, and it's the bug telling on itself, over and over. It pushes hard toward real infection[6][3]. Now picture the other version: one bottle positive, its partner stone silent. That's discordant growth, and for a skin commensal organism it is one of the most reassuring findings in all of microbiology.
Here's the number to keep in your back pocket. A lone bottle of CoNS in a two-bottle set — one up, one negative — carries roughly a 98% negative predictive value for true CoNS bacteraemia[6]. Read that again: in a patient with no hardware and no sepsis, that single bottle is contamination about nineteen times out of twenty. That one fact has spared more patients an unnecessary course of vancomycin than almost anything else in the stewardship toolkit — if the report makes the discordance clear instead of just stating "CoNS isolated."
Which leads to the rule we wish every ward internalised, and the one worth pushing in every CME and every collection-training session you run: draw enough sets, from separate sites. Two independent sets transform your ability to tell a true bacteraemia from a one-bottle skin commensal passenger[9]. One set isn't a blood culture. It's a coin flip in a lab coat — and when only one set arrives, that limitation belongs in your interpretive comment, because you are the only one who knows it's there.
Third questionHow fast did it grow?
The analyser hands you this one for free, and it's biology made visible: real bloodstream infection usually carries more organisms, so the bottle trips sooner.
The numbers are striking once you see them. Isolates that turn out to be real grow, on average, in around 18 hours. Contaminants dawdle in closer to 40[7]. The bench translation:
- Growth inside 24 hours leans pathogen. In one series, two-thirds of all true positives — and essentially none of the contaminants — had declared themselves by then[7].
- Growth after 48 hours, especially a textbook skin commensal organism, leans contaminant[7].
One caveat so the clock doesn't betray you: resistance slows the bug down. Methicillin-resistant staphylococci grow visibly later than their susceptible cousins, so a staph that's running a little behind schedule is not automatically off the hook[7]. Time-to-positivity is your best tiebreaker — not a verdict on its own.
Fourth questionWhose blood is this?
The exact same bottle means different things in different beds, because the patient sets the odds before the bug ever grows. And this is the information our requisitions are worst at giving us — so this is the question that most often means putting down the loop and chasing the ward, the file, or the treating unit for two minutes of history.
Lean toward "this is real," even for a low-virulence organism, when the patient is carrying a central line, a prosthetic valve, fresh surgery, an ICU or neonatal stay, a haematologic malignancy, or neutropenia[3][11][4]. Then layer the story on top: fever with a dropping blood pressure, a plausible source — a valve, a bone — and inflammatory markers (CRP, procalcitonin, a climbing white count) that all point the same way[11][12]. Each of those nudges a borderline CoNS from probably a skin commensal toward probably real.
And know your wards. Paediatric and oncology patients genuinely run a higher rate of true CoNS and other would-be contaminants, so an interpretive reflex calibrated on general adult medicine will quietly mislead you there[4][14]. The bench that reports for an oncology unit cannot use the same mental cut-off as the bench reporting for general medicine.
Now put them together
No single signal wins the argument. Their power is in agreement — which is exactly what the validated algorithms do: stack organism identity, time-to-positivity, the number of positives, and a quick clinical risk score into a single probability while susceptibilities are still cooking[13][12]. A classic CoNS model hit its sweet spot at about 62% sensitivity and 91% specificity only by weighing those features together, never one alone[12]. A paediatric ED model sorted children into clean tiers — 0%, 34%, 62% probability of true bacteraemia — with early growth (~19 hours) and an aggressive Gram morphology doing much of the heavy lifting[14].
So take the same four questions to two bottles sitting on your bench tonight.
Two patients, the same organism, opposite reports — and you can defend both. That's the whole craft.
One asymmetry to close on, because it overrides everything above: for a left-column organism — S. aureus, a streptococcus, an Enterobacterales, Candida — a single positive bottle is never dismissed. Ever. You report it and you ask for a repeat. The four-question framework is built for the grey zone. These organisms don't live there.
The decision: report, repeat, or suppress
Everything you just read exists to drive one of three moves — and all three are yours to make before the result leaves the lab.
Report it as significant when the story hangs together — a classic pathogen, concordant positives, fast growth, a fitting syndrome, or a line in the vein. Full identification, release susceptibilities, and where it matters, don't rely on the printed report alone — call the unit and ask for repeat cultures to prove it clears[13][3][11].
Sign out as equivocal and ask for a repeat when the signals quarrel — a borderline bug with one finger pointing each way. Report the isolate with an honest interpretive comment, hold the susceptibilities, and recommend a fresh set before anyone commits to broad-spectrum cover[9][8].
Suppress, with a documented reason, when everything converges on contamination: a single discordant bottle of a skin commensal organism, lazy growth, no sepsis, low-risk host. It's entirely reasonable to report "probable contaminant" and withhold the susceptibilities — but write down why, so the decision is yours on the record and not an unexplained silence the ward has to guess at[6][8][9].
None of this is academic hand-wringing. False positives drag whole chains behind them — needless antibiotics (vancomycin, again and again), longer stays, fatter bills — and labs that apply exactly these criteria have measurably cut both the misclassification and the reflex vancomycin[8][15][9]. And on our side of the bench there's one number that is purely ours to own: the long-standing target of keeping contamination at or below 3%[2]. Sit above it for long and you don't have an interpretation problem — you have a phlebotomy and collection-training problem, and fixing it is the one lever that lives entirely in the lab.
The checklist for 2 a.m.
When the bottle flags and the stain is drying, ask, in order:
- Who showed up? Left-column bug → report and repeat. Right-column → keep reading.
- How many bottles, and did they agree? Lone discordant skin commensal organism → ~98% likely contaminant — and say so in the comment.
- How fast? Under 24 h leans pathogen; over 48 h leans contaminant — but remember the resistant slow-growers.
- Whose blood is this? Lines, valves, neutropenia, a neonate, sepsis signs → trust the bug more, and chase the ward for the history the slip didn't give you.
- So: report, repeat, or suppress — and when you genuinely can't tell, sign it out as equivocal, recommend a repeat set, and pick up the phone before the ward reaches for broad-spectrum cover on your word[13][2][8].
Read the bottle as a probability, not a verdict, sign the report you can defend at the morning round, and most of those calls will answer themselves long before the sun — or the susceptibilities — come up.
References
- Thakar Y, Singh NN. Automated Blood Culture for the Detection of Septicemia. 2013.
- Dargère S, Cormier H, Verdon R. Contaminants in blood cultures: importance, implications, interpretation and prevention. Clin Microbiol Infect. 2018. doi:10.1016/J.CMI.2018.03.030.
- Kirchhoff LV, Sheagren JN. Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect Control Hosp Epidemiol. 1985;6(12):479–486. doi:10.1017/S0195941700063591.
- Chun S, Kang C-I, Kim Y-J, Lee NY. Clinical Significance of Isolates Known to Be Blood Culture Contaminants in Pediatric Patients. Medicina. 2019;55(10):696. doi:10.3390/MEDICINA55100696.
- Sidhu SK, Malhotra S, Devi P, Tuli AK. Significance of coagulase negative Staphylococcus from blood cultures: persisting problems and partial progress in resource constrained settings. Iran J Microbiol. 2016;8(6):366–371.
- Ben-Chetrit E, Helvitz Y, Levin PD. Diagnostic value of blood culture growth patterns in distinguishing contaminants from pathogens. J Clin Microbiol. 2026. doi:10.1128/jcm.01210-25.
- Balıkçı A, Belas Z, Topkaya AE. [Blood culture positivity: is it pathogen or contaminant?]. Mikrobiyol Bul. 2013;47(1):135–140. doi:10.5578/MB.4181.
- Richter SS, et al. Minimizing the Workup of Blood Culture Contaminants: Implementation and Evaluation of a Laboratory-Based Algorithm. J Clin Microbiol. 2002;40(7):2437–2444. doi:10.1128/JCM.40.7.2437-2444.2002.
- Lee CC, et al. Clinical significance of potential contaminants in blood cultures among patients in a medical center. J Microbiol Immunol Infect. 2007;40(5):438–444.
- Hamdan A, et al. Evaluating the Clinical Impact of Species-Level Identification in Coagulase-Negative Staphylococci Positive Blood Cultures. Antimicrob Steward Healthc Epidemiol. 2024;4(S1):s47–s48. doi:10.1017/ash.2024.162.
- Multidrug-Resistant Bacteria Isolated from Blood Culture Samples in a Moroccan Tertiary Hospital: True Bacteremia or Contamination? Infect Drug Resist. 2022;15:5691–5704. doi:10.2147/idr.s373065.
- Beekmann SE, Diekema DJ, Doern GV. Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol. 2005;26(6):559–566. doi:10.1086/502584.
- Bates DW, Lee TH. Rapid classification of positive blood cultures. Prospective validation of a multivariate algorithm. JAMA. 1992;267(14):1962–1966. doi:10.1001/JAMA.1992.03480140088039.
- Gravel J, et al. Discriminating bacteremia from contaminants among children with a preliminary positive blood culture in the emergency department. Paediatr Child Health. 2024;29(Suppl 1):e16–e17. doi:10.1093/pch/pxae067.034.
- Alahmadi YM, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect. 2011. doi:10.1016/J.JHIN.2010.09.033.
Bench to Bedside translates what the microbiology lab sees into what the ward should do. If a result has ever made you pause at the night bench — this is the place for you.